Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation

Abstract: High-dose posttransplantation cyclophosphamide (HD-PTCy), given at 50 mg/kg/day on days +3/+4, is a standard-of-care graft-versus-host disease (GVHD) prophylaxis for allogeneic hematopoietic cell transplantation (HCT). Our murine MHC–haploidentical HCT studies suggested intermediate-dose P...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Mustafa A. Hyder, Dimana Dimitrova, Ruby Sabina, Ashley DeVries, Jeannine S. McCune, Meredith J. McAdams, Francis A. Flomerfelt, Christi McKeown, Jennifer L. Sadler, Amy Chai, Thomas E. Hughes, Scott Napier, Anita Stokes, Jennifer Sponaugle, Kamil Rechache, Mark Parta, Jennifer Cuellar-Rodriguez, William D. Figg, Hyoyoung Choo-Wosoba, Seth M. Steinberg, Jennifer A. Kanakry, Christopher G. Kanakry
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2025-05-01
Sarja:	Blood Advances
Linkit:	http://www.sciencedirect.com/science/article/pii/S2473952925000734
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!